Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Optional
US Department of Health & Human Services: Food and Drug Administration (FDA)
Deadline: Nov 29, 2021
Grant amount: US $200,000 - US $1,000,000
Fields of work: Health Disparities & Social Determinants of Health
Applicant type: Organizations
Funding uses: Research
Location of project: United States
Location of residency: United States
The purpose of this funding opportunity announcement (FOA) is to fund innovative research that will strengthen and advance COVID-19 health equity research.
Areas of interest include:
- Proposals that focus on advancing racial and ethnic minority participation in COVID-19/COVID-19 variant clinical trials and/or contribute to informing the continued evaluation of the safety and efficacy of FDA approved products (therapeutics, diagnostics, and vaccines) or products subject to EUAs/EUA expansion for the treatment, prevention, or diagnosis of COVID-19.
- Proposals that support the evaluation of outcomes by demographic data including, but not limited to, ethnicity, race, age, disability, and geography.
- Proposals that support COVID-19 research to understand diverse patient perspectives, preferences, and unmet needs
We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's